|
|
TQ Evening Briefing |
Marvell's $1,132 bid for Lumentum was worth about $771 a share at the close. Crude fell 7%, and December hike odds still rose. |
Oil's Drop Stuck. Chips' Bounce Didn't.
The Dow rose 0.4%. The S&P 500 fell 0.5% and the Nasdaq 1.1%.
Chips joined the early bounce, then led the reversal. The Philadelphia chip index finished down 3.4%, after Friday's 7.2% drop. AMD (AMD) lost 7.5% a day before it reports. Intel (INTC) fell 8.8%.
U.S. crude settled down 7.1% at $96.73 a barrel. Delta Air Lines (DAL) rose 4.1%. The iShares U.S. Home Construction ETF gained 4.6%.
The 10-year yield slipped about 4 basis points to 4.89%. The VIX still rose above 21.
TQ Trade Implication
The tape paid companies that buy fuel or depend on lower rates. It sold AI hardware still carrying Friday's damage. Cheaper crude cuts airline costs right away, and builders gain from lower yields, while chip stocks have no such offset. A VIX above 21 on a Dow up day reads as defensive rotation, not risk appetite. If AMD can't hold a gain after its report, the selling may have moved past Intel's outlook.
Marvell Bid $1,132 for Lumentum. Its Stock Cut That to $771.
Marvell Technology (MRVL) agreed to buy Lumentum (LITE) for 4.5 Marvell shares apiece. The companies valued that at about $1,132 a share, on Oct. 28 prices.
The ratio is fixed. The price is not. The payout moves one for one with Marvell's stock, which has fallen about 32% since Oct. 28.
At the close, 4.5 Marvell shares were worth about $771. That is roughly 16% below Lumentum's own price on Oct. 28. Marvell fell 12.7% on Monday and Lumentum 18.6%. Lumentum also reported its quarter that morning.
Lumentum closed at $684.40, about 11% below the value of the shares it will receive.
Marvell would owe $5.8 billion in specified cases, and Lumentum $2.9 billion.
TQ Edge Setup
A signed, fee-protected deal rarely trades 11% below its deal value. With a fixed ratio, each $1 drop in Marvell's stock takes $4.50 off the payout per Lumentum share. The gap itself prices time and regulatory risk, with closing not expected until the first half of 2028. If the spread narrows while Marvell keeps sliding, traders are betting on completion, not the stock.
Oracle Set a $20 Billion Limit. Five Days Later It Asked for All of It.
At its Oct. 28 investor day, Oracle (ORCL) capped new capital raises through fiscal 2030 at $20 billion, half stock and half debt. The cap excludes refinancing of existing debt.
On Monday Oracle filed to sell $10 billion of stock and $10 billion of notes. Pricing is not set, and the filings don't say whether note proceeds refinance debt. The stock fell 8.9% to $119.10, below its close the day before the pledge.
It follows a $20 billion at-the-market stock sale finished this fiscal year. Its borrowings stood at about $125 billion at Aug. 31.
TQ Edge Setup
Last week Oracle's stock jumped 10.7% the day it limited its fundraising. Monday showed Oracle plans to draw the full allowance right away. Its plan has free cash flow turning positive only in the second half of fiscal 2028. Until then, the build-out leans on operating cash and partner financing. A deep discount at pricing would show what buyers charge to fund AI with Oracle stock.
FROM OUR PARTNERS
Why Did Trump Just Ban America's Most Powerful AI?
It's not Nvidia. It's not OpenAI. It's not Google.
It's a San Francisco AI lab whose technology is used by eight of the ten largest companies in America — and which Bloomberg calls the highest-revenue AI company on earth.
Trump banned it from every federal agency and the Pentagon blacklisted it. The reason isn't what you think. Full details here.
Oil Fell 7%. The Hike Odds Rose.
Iran says it can reopen Hormuz within two days if Washington meets its conditions. There is no agreement.
Pricing for a December hike did not fall with oil. CME FedWatch put the odds near 76%, up from about 73% on Friday.
The ISM report split. The headline index rose to 55.5, beating the 54.6 forecast. Production hit 59, the highest since November 2021. Prices paid fell to 75.2 from 77.9, below forecasts near 77.
September construction spending fell 1.9%. Private residential spending, which includes renovation, fell 5.5%. Homebuilder shares rallied anyway.
Polymarket's bet on the U.S.-Iran ceasefire lasting to Nov. 15 rose to 66.5 cents, from 54 early Monday. No single headline lined up with the climb.
TQ Execution Bias
Two inflation inputs cooled Monday: crude fell 7% and ISM prices paid dropped 2.7 points. Hike odds rose anyway, on a day factory output ran at its strongest since 2021. That suggests the December case now rests on activity rather than input costs. Cheaper fuel helps airlines directly, while homebuilders still need those odds to fall. If FedWatch holds above 70% with crude under $100, the setup keeps favoring airlines over homebuilders.
- Apple and Palantir beat after the close. Apple (AAPL) reported record September-quarter revenue of $114.5 billion, above the $113.4 billion expected. Its $2.10 a share included 5 cents from tariff refunds. Palantir (PLTR) grew revenue 96% to $2.31 billion and raised its full-year forecast. Its U.S. commercial sales passed U.S. government sales for the first time. Palantir rose about 1.5% in early after-hours trading.
- Binance's proof came early, and narrower.Binance completed a zero-knowledge proof of its Oct. 31 reserves a day ahead of schedule. Holders of 10 tokens can check their balances were backed at least one for one. The Oct. 1 report covered 55. The snapshot predates the reopening, so it misses later withdrawals. Coinbase (COIN) fell 4% and touched a new 52-week low.
- Strategy bought back more preferred than bitcoin. Strategy (MSTR) spent $208.2 million repurchasing its STRC preferred last week. That is about 3.2 times the $65.5 million it put into 811 bitcoin. Bitcoin ended near $76,700, less than 2% above Strategy's average cost.
- One private equity fund rationed withdrawals. Third-quarter requests at Partners Group's U.S. private equity evergreen fund hit $2.21 billion. The fund paid $728.4 million, its 5% cap, and prorated the rest. That is about a third of requests, versus 83% in the second quarter.
AI Financed With Stock. The Stock Fell.
Marvell's falling shares shrank its own bid, and Oracle's stock closed below its pre-pledge price after the filing. Chipmakers with no new paper fell nearly as hard. Cheaper oil lifted fuel buyers, and hike odds rose anyway.
AMD reports Tuesday after losing 7.5% Monday and 10.9% Friday. If it holds a gain, that would suggest Friday's rout was about Intel's outlook. Another drop would point to AI hardware being repriced as a group.
The Next AI Race Isn't About the Best Model.
Models improve. Computing gets cheaper. An algorithm can be matched.
What's hard to copy is a company's own lab data: experiments run at industrial scale, with every result fed back to make the AI smarter.
In drug development, that loop may become the edge that matters most. Not who has the best model. Who can learn biology fastest.
We profiled 5 companies building that loop in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.
Get the Free Report by Text →
|
|
|
|
Tidak ada komentar:
Posting Komentar